AZD2014 and Weekly Paclitaxel in Squamous NSCLC
Clinical trial NCT02403895 · TERMINATED
Trial details
- NCT number
- NCT02403895
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-15
- Primary completion
- 2016-12-29
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.